Uncommon Cents Investing LLC Has $2.58 Million Stake in CVS Health Corporation $CVS

Uncommon Cents Investing LLC raised its stake in shares of CVS Health Corporation (NYSE:CVS) by 3.9% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 37,345 shares of the pharmacy operator’s stock after buying an additional 1,406 shares during the period. Uncommon Cents Investing LLC’s holdings in CVS Health were worth $2,576,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of CVS. Wealth Enhancement Advisory Services LLC boosted its position in shares of CVS Health by 67.5% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 286,990 shares of the pharmacy operator’s stock valued at $12,883,000 after acquiring an additional 115,603 shares in the last quarter. MassMutual Private Wealth & Trust FSB boosted its position in shares of CVS Health by 41.4% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 4,719 shares of the pharmacy operator’s stock valued at $320,000 after acquiring an additional 1,381 shares in the last quarter. Versant Capital Management Inc boosted its position in shares of CVS Health by 308.6% during the 1st quarter. Versant Capital Management Inc now owns 4,061 shares of the pharmacy operator’s stock valued at $275,000 after acquiring an additional 3,067 shares in the last quarter. GAMMA Investing LLC boosted its position in shares of CVS Health by 20,124.3% during the 1st quarter. GAMMA Investing LLC now owns 1,264,825 shares of the pharmacy operator’s stock valued at $85,692,000 after acquiring an additional 1,258,571 shares in the last quarter. Finally, First County Bank CT acquired a new stake in shares of CVS Health during the 1st quarter valued at about $210,000. Institutional investors own 80.66% of the company’s stock.

Insider Buying and Selling at CVS Health

In other news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the transaction, the director directly owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This represents a 25.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.22% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms have commented on CVS. Baird R W upgraded shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 14th. Bernstein Bank reduced their price target on shares of CVS Health from $78.00 to $72.00 and set a “market perform” rating on the stock in a research report on Wednesday, July 16th. Wall Street Zen upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a research report on Sunday, September 21st. Sanford C. Bernstein boosted their price target on shares of CVS Health from $72.00 to $77.00 and gave the company a “market perform” rating in a research report on Friday, September 5th. Finally, Robert W. Baird upgraded shares of CVS Health from a “neutral” rating to an “outperform” rating and boosted their price target for the company from $71.00 to $82.00 in a research report on Thursday, August 14th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $78.25.

CVS Health Stock Up 1.6%

CVS Health stock opened at $75.80 on Friday. The stock has a market capitalization of $96.14 billion, a PE ratio of 21.17, a price-to-earnings-growth ratio of 0.84 and a beta of 0.62. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $77.34. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 0.74. The company has a 50 day moving average of $69.13 and a 200-day moving average of $66.99.

CVS Health (NYSE:CVS) last announced its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, topping the consensus estimate of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The business had revenue of $98.92 billion during the quarter, compared to analysts’ expectations of $94.87 billion. During the same quarter in the prior year, the company posted $1.83 earnings per share. The firm’s revenue was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be given a $0.665 dividend. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. CVS Health’s dividend payout ratio is presently 74.30%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.